1Davignon J, Ganz P (2004) Role of endothelial dysfunction in atherosclerosis. Circulation 109: 27-32.

2Huang PL (2009) eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab 20: 295-302.

3Liu VW, Huang PL (2008) Cardiovascular roles of nitric oxide: A review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res 77: 19-29.

4Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.

5Werner N, Nickenig G (2006) Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 10: 318-332.

6Urbich C, Dimmeler S (2004) Endothelial progenitor cells: Characterization and role in vascular biology. Circ Res 95: 343-353.

7Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, et al. (2002) Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109: 625-637.

8Aicher A, Heeschen C, Mildner-Rihm C, Urbich C, Ihling C, et al. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat Med 9: 1370-1376.

9Iwakura A, Luedemann C, Shastry S, Hanley A, Kearney M, et al. (2003) Estrogen-mediated, endothelial nitric oxide synthase-dependent mobilization of bone marrow-derived endothelial progenitor cells contributes to reendothelialization after arterial injury. Circulation 108: 3115-3121.

10Landmesser U, Engberding N, Bahlmann FH, Schaefer A, Wiencke A, et al. (2004) Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. Circulation 110: 1933-1939.

11L Laufs U, Werner N, Link A, Endres M, Wassmann S, et al. (2004) Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 109: 220-226.

12Goldstein LJ, Gallagher KA, Bauer SM, Bauer RJ, Baireddy V, et al. (2006) Endothelial progenitor cell release into circulation is triggered by hyperoxiainduced increases in bone marrow nitric oxide. Stem Cells 24: 2309-2318.

13Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, et al. (2006) Erythropoietin- mobilized endothelial progenitors enhance reendothelialization via akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98: 1405-1413.

14Schgoer W, Theurl M, Jeschke J, Beer AG, Albrecht K, et al. (2009) Gene therapy with the angiogenic cytokine secretoneurin induces therapeutic angiogenesis by a nitric oxide-dependent mechanism. Circ Res 105: 994-1002.

15Wegiel B, Gallo DJ, Raman KG, Karlsson JM, Ozanich B, et al. (2010) Nitric oxide-dependent bone marrow progenitor mobilization by carbon monoxide enhances endothelial repair after vascular injury. Circulation 121: 537-548.

16Fraccarollo D, Widder JD, Galuppo P, Thum T, Tsikas D, et al. (2008) Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer ave9488 after experimental myocardial infarction. Circulation 118: 818-827.

17Javanmard SH, Gheisari Y, Soleimani M, Nematbakhsh M, Monajemi A (2010) Effect of l-arginine on circulating endothelial progenitor cells in hypercholesterolemic rabbits. Int J Cardiol 143: 213-216.

18Thum T, Tsikas D, Stein S, Schultheiss M, Eigenthaler M, et al. (2005) Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. J Am Coll Cardiol 46: 1693-1701.

19Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, et al. (2007) The phosphorylation state of enos modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest 117: 1961-1967.

20Schleicher M, Yu J, Murata T, Derakhshan B, Atochin D, et al. (2009) The akt1-enos axis illustrates the specificity of kinase-substrate relationships in vivo. Sci Signal 2: ra41.

21 Kashiwagi S, Atochin DN, Li Q, Schleicher M, Pong T, et al. (2013) Enos phosphorylation on serine 1176 affects insulin sensitivity and adiposity. Biochem Biophys Res Commun 431: 284-290

22 Kuhlencordt PJ, Gyurko R, Han F, Scherrer-Crosbie M, Aretz TH, et al. (2001) Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein e/endothelial nitric oxide synthase doubleknockout mice. Circulation 104: 448-454.

23Chang J, Li Y, Huang Y, Lam KS, Hoo RL, et al. (2010) Adiponectin prevents diabetic premature senescence of endothelial progenitor cells and promotes endothelial repair by suppressing the p38 map kinase/p16ink4a signaling pathway. Diabetes 59: 2949-2959

24Hagensen MK, Shim J, Thim T, Falk E, Bentzon JF (2010) Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 121: 898-905.

25Yu J, deMuinck ED, Zhuang Z, Drinane M, Kauser K, et al. (2005) Endothelial nitric oxide synthase is critical for ischemic remodeling, mural cell recruitment, and blood flow reserve. Proc Natl Acad Sci U S A 102: 10999- 11004.

26Nowak G, Karrar A, Holmen C, Nava S, Uzunel M, et al. (2004) Expression of vascular endothelial growth factor receptor-2 or tie-2 on peripheral blood cells defines functionally competent cell populations capable of reendothelialization. Circulation 110: 3699-3707.

27Lindner V, Fingerle J, Reidy MA (1993) Mouse model of arterial injury. Circ Res 73: 792-796.

28Brouchet L, Krust A, Dupont S, Chambon P, Bayard F, et al. (2001) Estradiol accelerates reendothelialization in mouse carotid artery through estrogen receptor-alpha but not estrogen receptor-beta. Circulation 103: 423-428

29 Weidinger FF, McLenachan JM, Cybulsky MI, Gordon JB, Rennke HG, et al. (1990) Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery. Circulation 81: 1667-1679.

30Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, et al. (1994) Long-term oral administration of l-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation 90: 1357-1362

31Schwarzacher SP, Lim TT, Wang B, Kernoff RS, Niebauer J, et al. (1997) Local intramural delivery of l-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 95: 1863-1869.

32Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, et al. (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348: 593-600.

33Schmidt-Lucke C, Rössig L, Fichtlscherer S, Vasa M, Britten M, et al. (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987.

34 Yang L, Soonpaa MH, Adler ED, Roepke TK, Kattman SJ, et al. (2008) Human cardiovascular progenitor cells develop from a kdr+ embryonic-stemcell- derived population. Nature 453: 524-528.

35 Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, et al. (2000) Expression of vegfr-2 and ac133 by circulating human cd34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.

36 Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, et al. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8: 607-612

37 Lin Y, Weisdorf DJ, Solovey A, Hebbel RP (2000) Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105: 71-77.

38 Ozuyaman B, Ebner P, Niesler U, Ziemann J, Kleinbongard P, et al. (2005) Nitric oxide differentially regulates proliferation and mobilization of endothelial progenitor cells but not of hematopoietic stem cells. Thromb Haemost 94: 770-772.

39 Noor R, Shuaib U, Wang CX, Todd K, Ghani U, et al. (2007) High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing enos and preventing apoptosis. Atherosclerosis 192: 92-99.

40Sorrentino SA, Bahlmann FH, Besler C, Müller M, Schulz S, et al. (2007) Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: Restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation 116: 163-173.

41Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, et al. (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 56: 666-674.

42Thum T, Hoeber S, Froese S, Klink I, Stichtenoth DO, et al. (2007) Agedependent impairment of endothelial progenitor cells is corrected by growthhormone- mediated increase of insulin-like growth-factor-1. Circ Res 100: 434-443.

43 Ii M, Nishimura H, Iwakura A, Wecker A, Eaton E, et al. (2005) Endothelial progenitor cells are rapidly recruited to myocardium and mediate protective effect of ischemic preconditioning via "imported" nitric oxide synthase activity. Circulation 111: 1114-1120.